Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Midatech Pharma plc

9 Jun 2020 12:14

RNS Number : 4235P
Berenberg
09 June 2020
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Joh. Berenberg, Gossler & Co. KG

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Midatech Pharma PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

8th June 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.1 pence ordinary shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,692,295

4.31%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

1,692,295

4.31%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit- GBP

0.1 pence ordinary shares

Purchase

250000

23

0.1 pence ordinary shares

Purchase

3641285

21

0.1 pence ordinary shares

Purchase

25000

22.05

0.1 pence ordinary shares

Purchase

11253

23.85

0.1 pence ordinary shares

Purchase

10000

24

0.1 pence ordinary shares

Purchase

5000

23.4

0.1 pence ordinary shares

Purchase

10000

22.4

0.1 pence ordinary shares

Purchase

2012

22.45

0.1 pence ordinary shares

Purchase

10514

22.65

0.1 pence ordinary shares

Purchase

6000

22.7

0.1 pence ordinary shares

Purchase

8308

22.8

0.1 pence ordinary shares

Purchase

1733

22.82

0.1 pence ordinary shares

Sale

5677

24.44

0.1 pence ordinary shares

Sale

8172

24.4

0.1 pence ordinary shares

Sale

1000

24.34999

0.1 pence ordinary shares

Sale

18000

24.34999

0.1 pence ordinary shares

Sale

1000

24.1

0.1 pence ordinary shares

Sale

250

23.455

0.1 pence ordinary shares

Sale

10641

23.455

0.1 pence ordinary shares

Sale

25000

23.455

0.1 pence ordinary shares

Sale

25000

23.455

0.1 pence ordinary shares

Sale

20611

23.4

0.1 pence ordinary shares

Sale

5000

23.4

0.1 pence ordinary shares

Sale

2115

23.4

0.1 pence ordinary shares

Sale

3900

23.4

0.1 pence ordinary shares

Sale

2653

23

0.1 pence ordinary shares

Sale

50000

23

0.1 pence ordinary shares

Sale

1074

23

0.1 pence ordinary shares

Sale

4513

23

0.1 pence ordinary shares

Sale

1413

23

0.1 pence ordinary shares

Sale

15000

23

0.1 pence ordinary shares

Sale

5000

23.25

0.1 pence ordinary shares

Sale

29630

23.25

0.1 pence ordinary shares

Sale

5000

23.25

0.1 pence ordinary shares

Sale

4247

23.25

0.1 pence ordinary shares

Sale

21505

23.25

0.1 pence ordinary shares

Sale

4000

23.25

0.1 pence ordinary shares

Sale

5000

23.25

0.1 pence ordinary shares

Sale

350

23.25

0.1 pence ordinary shares

Sale

10129

23.25

0.1 pence ordinary shares

Sale

2173

23

0.1 pence ordinary shares

Sale

1282

23

0.1 pence ordinary shares

Sale

195

23

0.1 pence ordinary shares

Sale

2500

23

0.1 pence ordinary shares

Sale

5217

23

0.1 pence ordinary shares

Sale

10869

23

0.1 pence ordinary shares

Sale

10000

23

0.1 pence ordinary shares

Sale

250000

22.64

0.1 pence ordinary shares

Sale

9213

23.25

0.1 pence ordinary shares

Sale

500

23

0.1 pence ordinary shares

Sale

1000

23

0.1 pence ordinary shares

Sale

10000

22.75

0.1 pence ordinary shares

Sale

1000

22.75

0.1 pence ordinary shares

Sale

25000

22.2

0.1 pence ordinary shares

Sale

50000

22.1

0.1 pence ordinary shares

Sale

2675

22.2

0.1 pence ordinary shares

Sale

1351

22.2

0.1 pence ordinary shares

Sale

8970

22.25

0.1 pence ordinary shares

Sale

5000

22.5

0.1 pence ordinary shares

Sale

7607

22.4

0.1 pence ordinary shares

Sale

11253

22.4

0.1 pence ordinary shares

Sale

12000

22.4

0.1 pence ordinary shares

Sale

40000

22.9

0.1 pence ordinary shares

Sale

2232

22.4

0.1 pence ordinary shares

Sale

100000

22.4

0.1 pence ordinary shares

Sale

100000

22.3

0.1 pence ordinary shares

Sale

25000

22.4

0.1 pence ordinary shares

Sale

100000

22.4

0.1 pence ordinary shares

Sale

10000

22.4

0.1 pence ordinary shares

Sale

100000

22.4

0.1 pence ordinary shares

Sale

100000

22.4

0.1 pence ordinary shares

Sale

100000

22.4

0.1 pence ordinary shares

Sale

90000

22.4

0.1 pence ordinary shares

Sale

102652

22.4

0.1 pence ordinary shares

Sale

15000

22.4

0.1 pence ordinary shares

Sale

10000

22.6

0.1 pence ordinary shares

Sale

10000

22.6

0.1 pence ordinary shares

Sale

10000

22.6

0.1 pence ordinary shares

Sale

11137

22.7

0.1 pence ordinary shares

Sale

10000

22.8

0.1 pence ordinary shares

Sale

8902

22.4

0.1 pence ordinary shares

Sale

4437

22.4

0.1 pence ordinary shares

Sale

5000

22.4

0.1 pence ordinary shares

Sale

7985

22.4

0.1 pence ordinary shares

Sale

1631

22.6

0.1 pence ordinary shares

Sale

2186

22.6

0.1 pence ordinary shares

Sale

2186

22.6

0.1 pence ordinary shares

Sale

4398

22.6

0.1 pence ordinary shares

Sale

4385

22.6

0.1 pence ordinary shares

Sale

4398

22.6

0.1 pence ordinary shares

Sale

12500

22.6

0.1 pence ordinary shares

Sale

5683

22.6

0.1 pence ordinary shares

Sale

15000

22.8

0.1 pence ordinary shares

Sale

6000

22.8

0.1 pence ordinary shares

Sale

2280

22.8

0.1 pence ordinary shares

Sale

17517

22.8

0.1 pence ordinary shares

Sale

90000

22.8

0.1 pence ordinary shares

Sale

131552

22.8

0.1 pence ordinary shares

Sale

40000

23

0.1 pence ordinary shares

Sale

5308

23

0.1 pence ordinary shares

Sale

626

23

0.1 pence ordinary shares

Sale

12610

23

0.1 pence ordinary shares

Sale

4356

23

0.1 pence ordinary shares

Sale

9756

23

0.1 pence ordinary shares

Sale

5000

23

0.1 pence ordinary shares

Sale

21704

23

0.1 pence ordinary shares

Sale

3746

23

0.1 pence ordinary shares

Sale

2148

23

0.1 pence ordinary shares

Sale

100000

23

0.1 pence ordinary shares

Sale

1000

23.2

0.1 pence ordinary shares

Sale

5000

23.4

0.1 pence ordinary shares

Sale

5000

23.6

0.1 pence ordinary shares

Sale

25000

23.8

0.1 pence ordinary shares

Sale

15000

24

0.1 pence ordinary shares

Sale

1733

24

0.1 pence ordinary shares

Sale

2500

24

0.1 pence ordinary shares

Sale

8291

24

0.1 pence ordinary shares

Sale

2900

24

0.1 pence ordinary shares

Sale

4141

24

0.1 pence ordinary shares

Sale

8183

24

0.1 pence ordinary shares

Sale

4141

24

0.1 pence ordinary shares

Sale

25000

24

0.1 pence ordinary shares

Sale

8000

24.2

0.1 pence ordinary shares

Sale

1819

24

0.1 pence ordinary shares

Sale

5000

24

0.1 pence ordinary shares

Sale

50000

23.6

0.1 pence ordinary shares

Sale

41966

23.8

0.1 pence ordinary shares

Sale

6016

24.8

0.1 pence ordinary shares

Sale

8040

24.8

0.1 pence ordinary shares

Sale

3984

24.8

0.1 pence ordinary shares

Sale

15969

24.8

0.1 pence ordinary shares

Sale

20000

25

0.1 pence ordinary shares

Sale

1007

25

0.1 pence ordinary shares

Sale

1000

24.99999

0.1 pence ordinary shares

Sale

2756

24.96

0.1 pence ordinary shares

Sale

17338

24.8

0.1 pence ordinary shares

Sale

10080

24.8

0.1 pence ordinary shares

Sale

1209

24.8

0.1 pence ordinary shares

Sale

3989

24.75

0.1 pence ordinary shares

Sale

2044

24.45

0.1 pence ordinary shares

Sale

2027

24.37

0.1 pence ordinary shares

Sale

4123

24.25

0.1 pence ordinary shares

Sale

2037

24.25

0.1 pence ordinary shares

Sale

15031

24.25

0.1 pence ordinary shares

Sale

41650

24

0.1 pence ordinary shares

Sale

5000

23

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

9th June 2020

Contact name:

Daniel Stephens

Telephone number*:

020 3207 7881

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETEAFKNEFAEEFA
Date   Source Headline
10th Mar 20235:52 pmRNSFurther re: Notice of General Meeting
8th Mar 20237:00 amRNSPosting of Circular and Notice of General Meeting
17th Feb 20237:00 amRNSHolding(s) in Company
16th Feb 20237:00 amRNSHolding(s) in Company
15th Feb 20232:49 pmRNSHolding(s) in Company
15th Feb 20231:36 pmRNSHolding(s) in Company
15th Feb 20231:26 pmRNSHolding(s) in Company
15th Feb 20238:05 amRNSClosing of $6.0m Private Placement & Broker Change
9th Feb 20235:10 pmRNSPrivate Placement Raising US$6.0 million
3rd Feb 20239:57 amRNSReceipt of NASDAQ Notice
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 202312:00 pmRNSResult of General Meeting
16th Jan 202311:24 amRNSHolding(s) in Company
12th Jan 20237:00 amRNSPlanned Dose Escalation in MTX-110 Phase 1 Study
6th Jan 20237:00 amRNSPosting of Circular and Notice of General Meeting
19th Dec 202212:06 pmRNSHolding(s) in Company
19th Dec 202210:48 amRNSHolding(s) in Company
19th Dec 20227:00 amRNSClosing of Offering, Revised Terms, AIM & Webinar
14th Dec 20222:05 pmRNSSecond Price Monitoring Extn
14th Dec 20222:00 pmRNSPrice Monitoring Extension
13th Dec 20224:40 pmRNSSecond Price Monitoring Extn
13th Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 20223:22 pmRNSProposed Acquisition of Bioasis Technologies Inc
14th Nov 20227:00 amRNSFirst Patient Enrolled in Phase 1 Study of MTX-110
18th Oct 20227:00 amRNSReceipt of NASDAQ Notification
20th Sep 202211:51 amRNSHolding(s) in Company
14th Sep 20221:57 pmRNSADR Ratio Change
14th Sep 20227:00 amRNSInterim results for the six months to 30 June 2022
21st Jun 20227:00 amRNSMTX110 Development for the Treatment of Glioma
20th Jun 20225:58 pmRNSDirectorate Change
20th Jun 20222:33 pmRNSResult of 2022 Annual General Meeting
10th Jun 20227:00 amRNSRetirement of Chairman and Proposed New Chairman
10th Jun 20227:00 amRNSMTX110 Study to be Presented at ISPNO 2022
1st Jun 202212:23 pmRNSFast Track Designation for MTX110 Development
24th May 202211:09 amRNSPosting of Annual Report & Notice of AGM
27th Apr 20221:00 pmRNSIssue of Equity for Employee Share Incentive Plan
26th Apr 20227:00 amRNSResults for the Year Ended 31 December 2021
14th Apr 202212:37 pmRNSReceipt of NASDAQ Notice
17th Mar 20227:00 amRNSExercise of Warrants and Issue of Equity
9th Mar 20227:00 amRNSR&D collaboration with Janssen on second molecule
8th Mar 20229:30 amRNSAppointment of Nominated and Financial Adviser
9th Feb 20221:53 pmRNSHolding(s) in Company
18th Jan 20224:18 pmRNSHolding(s) in Company
17th Jan 20227:00 amRNSExtension of Janssen collaboration re Q-Sphera
7th Jan 20225:37 pmRNSHolding(s) in Company
13th Dec 20219:43 amRNSIND Application for MTX110 Study in GBM Effective
3rd Dec 20217:00 amRNSMidatech presenting at MelloMonday
24th Nov 20217:00 amRNSMidatech presenting at the Shares/AJ Bell Webinar
17th Sep 20219:31 amRNSInterim results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.